Scarica l'app Stockscreener
1.49
1.36%
0.02
Dopo l'orario di chiusura:
1.50
0.01
+0.67%
Precedente Chiudi:
$1.47
Aprire:
$1.44
Volume 24 ore:
206.46K
Relative Volume:
0.17
Capitalizzazione di mercato:
$25.21M
Reddito:
-
Utile/perdita netta:
$-11.24M
Rapporto P/E:
-1.9567
EPS:
-0.7615
Flusso di cassa netto:
$-4.79M
1 W Prestazione:
+4.20%
1M Prestazione:
+16.41%
6M Prestazione:
+25.21%
1 anno Prestazione:
-27.32%
Intervallo 1D:
$1.44
$1.50
Intervallo di 1 settimana:
$1.35
$1.50
Portata 52W:
$0.73
$2.70
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Nome
Mira Pharmaceuticals Inc
Settore
Industria
Telefono
813-369-5150
Indirizzo
1200 BRICKELL AVENUE, MIAMI
Confronta MIRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.49 | 26.23M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
660.49 | 569.45B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
174.42 | 418.62B | 90.63B | 22.66B | 16.40B | 9.35 |
|
ABBV
Abbvie Inc
|
201.47 | 350.91B | 58.33B | 3.76B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
121.20 | 229.50B | 55.19B | 13.65B | 16.81B | 6.86 |
|
MRK
Merck Co Inc
|
82.71 | 199.90B | 63.62B | 16.41B | 14.72B | 6.49 |
Mira Pharmaceuticals Inc Borsa (MIRA) Ultime notizie
Applying Elliott Wave Theory to MIRA Pharmaceuticals Inc.Product Launch & Real-Time Stock Movement Alerts - Newser
Combining price and volume data for MIRA Pharmaceuticals Inc.2025 Institutional Moves & Fast Gaining Stock Strategy Reports - Newser
Understanding MIRA Pharmaceuticals Inc.’s price movementMarket Weekly Review & Fast Exit/Entry Strategy Plans - Newser
Analyzing drawdowns of MIRA Pharmaceuticals Inc. with statistical toolsWeekly Profit Recap & Weekly Breakout Watchlists - Newser
Published on: 2025-08-13 06:59:24 - Newser
Published on: 2025-08-13 05:51:00 - Newser
How moving averages guide MIRA Pharmaceuticals Inc. tradingStock Market Watch with Smart Filters - Newser
MIRA Pharmaceuticals Inc. stock trendline breakdownJuly 2025 PreEarnings & Accurate Intraday Trade Tips - Newser
MIRA Pharmaceuticals Announces Virtual Annual Meeting to Discuss SKNY Merger - MSN
Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.
MIRA Pharmaceuticals’ Ketamir-2 Shows Promising Preclinical Results - TipRanks
MIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin - ACCESS Newswire
Breakthrough: New Oral Pain Drug Shows Superior Results vs Ketamine, Targets $16.8B Market - Stock Titan
MIRA Pharmaceuticals’ Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin - Sarasota Herald-Tribune
MIRA: Ketamir-2 Paper Accepted; Phase 2a Submission Planned Q4 2025 | MIRA SEC FilingForm 8-K - Stock Titan
How to build a custom watchlist for MIRA Pharmaceuticals Inc.Free Market Surge Signal for Swing Traders - Newser
Published on: 2025-08-11 04:11:26 - Newser
Visual trend scoring systems applied to MIRA Pharmaceuticals Inc.AI Pattern Recognition and Trade Prediction - Newser
What to expect from MIRA Pharmaceuticals Inc. in the next 30 daysFree Profit Target Stock Opportunity Monitor - Newser
Volume spikes in MIRA Pharmaceuticals Inc. stock – what they meanAsset Allocation Summary With Future Outlook - Newser
MIRA Pharmaceuticals (MIRA) Projected to Post Quarterly Earnings on Tuesday - Defense World
Real time scanner hits for MIRA Pharmaceuticals Inc. explainedFree Alert Feed for Momentum Based Picks - Newser
Is it too late to sell MIRA Pharmaceuticals Inc.Pattern Breakout Prediction for Short Term - Newser
What earnings revisions data tells us about Regulus Therapeutics Inc.Stock Price Prediction Using AI Tools - Newser
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study - The Florida Times-Union
What makes MIRA Pharmaceuticals Inc. stock price move sharplyUncover the best stocks for explosive growth - Jammu Links News
What analysts say about MIRA Pharmaceuticals Inc. stockAchieve rapid returns with smart investment plans - Jammu Links News
When is MIRA Pharmaceuticals Inc. stock expected to show significant growthBuild a strong portfolio for long-term success - Jammu Links News
What are MIRA Pharmaceuticals Inc. company’s key revenue driversExceptional stock performance - Jammu Links News
Is MIRA Pharmaceuticals Inc. stock overvalued or undervaluedInvest confidently with daily market forecasts - Jammu Links News
Published on: 2025-08-03 20:19:04 - Jammu Links News
Is MIRA Pharmaceuticals Inc. a growth stock or a value stockAchieve exceptional returns with expert guidance - Jammu Links News
What are the latest earnings results for MIRA Pharmaceuticals Inc.Free Capital Growth Strategies - Jammu Links News
Why is MIRA Pharmaceuticals Inc. stock attracting strong analyst attentionExplosive earning power - Jammu Links News
Does MIRA Pharmaceuticals Inc. stock perform well during market downturnsHigh-return market picks - Jammu Links News
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Up 414.4% in July - Defense World
What is MIRA Pharmaceuticals Inc. company’s growth strategyFinancial News Target Finder That Work - Jammu Links News
What are the technical indicators suggesting about MIRA Pharmaceuticals Inc.Advanced Screener Report With Low Risk - Jammu Links News
MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program - Sentinel-Standard
What catalysts could drive MIRA Pharmaceuticals Inc. stock higher in 2025Post Market Target Finder To Watch Now - Jammu Links News
Mira Pharmaceuticals Inc Azioni (MIRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):